Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation-Reference-Cited by-同舟云学术

Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation

Published:2020-08 Issue:8 Volume:22 Page:450-457
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Damodharan Sudarshawn N.,Walker Kirsti L.,Forsberg Matthew H.,McDowell Kimberly A.,Bouchlaka Myriam N.,Drier Diana A.,Sondel Paul M.,DeSantes Kenneth B.,Capitini Christian M.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference55 articles.

1. Expansion and activation of natural killer cells for cancer immunotherapy;Cho;Korean J Lab Med,2009

2. Cytotoxicity of activated natural killer cells against pediatric solid tumors;Cho;Clin Cancer Res,2010

3. What fuels natural killers? Metabolism and NK cell responses;Gardiner;Front Immunol,2017

4. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer;Miller;Blood,2005

5. Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation;Passweg;Leukemia,2004

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A scalable, spin‐free approach to generate enhanced induced pluripotent stem cell–derived natural killer cells for cancer immunotherapy;Immunology & Cell Biology;2024-09-13

2. Cryopreservation of Immune Cells: Recent Progress and Challenges Ahead;Advanced Biology;2024-08-07

3. Stem Cell Therapy as a Potential Treatment of Non-Alcoholic Steatohepatitis-Related End-Stage Liver Disease: A Narrative Review;Current Stem Cell Reports;2024-07-02

4. Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation;Nature Communications;2024-05-10

5. Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing;PLOS ONE;2024-02-23